بيكالوتاميد تيڤع ١٥٠ ملغ
teva pharmaceutical indust.ltd - bicalutamide 150 mg - tablets - bicalutamide - in patients with locally advanced prostate cancer (t3-t4 any n m0 t1-t2 n+ m0) bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.
bicalutamida bluefish 50mg 30 comprimidos recubiertos pelicula efg
bicalutamida pensa 50mg 30 comprim recub pelic efg
bicalutamida aristo efg 50 mg 30 comprimits recoberts
bicalutamida sandoz 50mg 30 comprimidos recubiertos pelicula efg
bicalutamida apotex 50mg 30 comprimidos recubiertos pelicula efg
bicalutamida stada 50mg 30 comprimidos recubiertos con pelicula efg
bicalutamida kern pharma 50mg 30 comprimidos rec con pelicula efg
bicalutamida teva 50mg 30 comprimidos recubiertos con pelicula efg
bicalutamida aristo 50mg 30 comprimidos recubiertos pelicula efg